News | March 16, 2009

New Vendors Elected to Serve on ASTRO’s Advisory Council

March 17, 2009 - The American Society for Radiation Oncology (ASTRO) said that Calypso Medical, Standard Imaging and Varian Medical Systems have been elected to serve three-year terms on ASTRO's Corporate Advisory Council.

PTW New York was also elected to serve the balance of a term vacated by Carestream Health. These companies were elected by ASTRO's corporate membership and were approved by the ASTRO Board of Directors.

"It is very important for ASTRO to maintain a good working relationship with our industry partners as these companies continue to innovate tools that help our physician members use radiation therapy to treat and cure people living with a diagnosis of cancer," said Hak Choy, M.D., chair of ASTRO's corporate relations committee and a radiation oncologist at the University of Texas Southwestern Medical Center in Dallas. "We believe that fostering this forum helps our society successfully connect the patient, doctor and industry in targeting cancer care."

The Corporate Advisory Council is a representative body of ASTRO's corporate membership, consisting of nearly 100 equipment, device and pharmaceutical companies who are involved in radiation therapy. Council seats are balanced between small-, medium- and large-sized corporations, represent a cross section of the radiation oncology industry and are elected positions. The goal of the council is to focus on issues of mutual concern to all corporate members and to increase awareness of radiation therapy and advance the science and practice of radiation therapy in the treatment of cancer.

A complete council listing with term expirations is as follows:
PTW New York - 2009
Elekta/Impac/CMS - 2009
James L. Davis - 2009
BrainLab - 2010
GE Healthcare - 2010
Multidata Systems - 2010
Calypso Medical - 2011
Standard Imaging - 2011
Varian Medical Systems – 2011

For more information:

Related Content

Videos | Mammography | December 10, 2018
Stamatia Destounis, M.D., FACR, associate professor, University of Rochester School of Medicine, and attending radiol
FDA Clears iCAD's ProFound AI for Digital Breast Tomosynthesis
Technology | Mammography | December 07, 2018
iCAD Inc. announced clearance by the U.S. Food and Drug Administration (FDA) for their latest, deep-learning, cancer...
Fujifilm Collaborates With Lunit on AI Pilot Project
News | Artificial Intelligence | December 05, 2018
Fujifilm Medical Systems USA Inc. announced a joint collaboration with Korean-based medical artificial intelligence (AI...
ScreenPoint Medical and Volpara Partner to Bring AI to Breast Imaging Clinics
News | Computer-Aided Detection Software | December 04, 2018
ScreenPoint Medical has signed a memorandum of understanding (MOU) with Volpara Health Technologies. Volpara will...
GE Healthcare Introduces Invenia ABUS 2.0
Technology | Ultrasound Women's Health | December 03, 2018
GE Healthcare recently launched the Invenia automated breast ultrasound (ABUS) 2.0 system in the United States. This...
Sponsored Content | Videos | Radiation Oncology | November 30, 2018
Accuray's philosophy is to personalize treatments to exactly fit the patient.
Snoring Poses Greater Cardiac Risk to Women
News | Women's Health | November 29, 2018
Obstructive sleep apnea (OSA) and snoring may lead to earlier impairment of cardiac function in women than in men,...
ScreenPoint Medical Receives FDA Clearance for Transpara Mammography AI Solution
Technology | Computer-Aided Detection Software | November 28, 2018
November 28, 2018 — ScreenPoint Medical announced it has received 510(k) clearance from the U.S.
Women Benefit From Mammography Screening Beyond Age 75
News | Mammography | November 26, 2018
Women age 75 years and older should continue to get screening mammograms because of the comparatively high incidence of...